Cargando…

Time course of conjunctival hyperemia induced by omidenepag isopropyl ophthalmic solution 0.002%: a pilot, comparative study versus ripasudil 0.4%

OBJECTIVE: We investigated the detailed time course of conjunctival hyperemia induced by omidenepag isopropyl ophthalmic solution 0.002% (omidenepag), a selective prostaglandin E2 receptor 2 agonist. METHODS AND ANALYSIS: We recruited 34 healthy subjects and administered omidenepag in the right eye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terao, Etsuko, Nakakura, Shunsuke, Fujisawa, Yasuko, Nagata, Yuki, Ueda, Kanae, Kobayashi, Yui, Oogi, Satomi, Dote, Saki, Shiraishi, Miku, Tabuchi, Hitoshi, Yoneda, Tsuyoshi, Fukushima, Atsuki, Asaoka, Ryo, Kiuchi, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398095/ https://www.ncbi.nlm.nih.gov/pubmed/32818152 http://dx.doi.org/10.1136/bmjophth-2020-000538

Ejemplares similares

Evaluation of Patterns and Correlations of the Degree of Conjunctival Hyperemia Induced by Omidenepag Isopropyl 0.002% and Ripasudil 0.4%
por: Terao, Etsuko, et al.
Publicado: (2020)

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
por: Shiratori, Naka, et al.
Publicado: (2021)

Efficacy and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution: A Retrospective Analysis of Real-World Data in Japan
por: Miki, Atsuya, et al.
Publicado: (2022)

Evaluation of offset of conjunctival hyperemia induced by a Rho-kinase inhibitor; 0.4% Ripasudil ophthalmic solution clinical trial
por: Sakamoto, Emi, et al.
Publicado: (2019)

One-Year Follow-Up Study of Changes in Prostaglandin-Associated Periorbital Syndrome After Switch From Conventional Prostaglandin F2alfa to Omidenepag Isopropyl
por: Oogi, Satomi, et al.
Publicado: (2020)

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
por: Olander, Kenneth W., et al.
Publicado: (2021)

Efficacy and safety of a fixed combination of 1% brinzolamide and 0.1% brimonidine as treatment for glaucoma: a retrospective study focusing on the number of ingredients
por: Aoki, Ryota, et al.
Publicado: (2022)

Case Report: Microincision Vitreous Surgery Induces Bleb Failure in Eyes With Functional Filtering Bleb
por: Oogi, Satomi, et al.
Publicado: (2022)

Evaluation of New and Preexisting Epiretinal Membranes Following Glaucoma Filtration Surgery
por: Aoki, Ryota, et al.
Publicado: (2023)

Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study
por: Nakakura, Shunsuke, et al.
Publicado: (2021)

Case report: Medical treatment for limbal epithelial stem cell deficiency in patients treated for glaucoma
por: Nakakura, Shunsuke, et al.
Publicado: (2023)

Effect of idiopathic epiretinal membrane on macular ganglion cell complex measurement in eyes with glaucoma
por: Nakakura, Shunsuke, et al.
Publicado: (2022)

Evaluation of rebound tonometer iCare IC200 as compared with IcarePRO and Goldmann applanation tonometer in patients with glaucoma
por: Nakakura, Shunsuke, et al.
Publicado: (2021)

Measurements of the nucleon structure function in the range 0.002 $<$ x $<$ 0.17 and 0.2 $<$ Q$^{2}$ $<$ 8 GeV$^{2}$ in deuterium, carbon and calcium
por: Arneodo, M, et al.
Publicado: (1989)

Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension
por: Matsuo, Masato, et al.
Publicado: (2022)

Short-Term Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2020)

Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
por: Nakazawa, Toru, et al.
Publicado: (2022)

CHARGE Syndrome Associated with Angle Closure despite High Myopia: A Case Report with Structural Suggestion
por: Dote, Saki, et al.
Publicado: (2020)

A comparison of continuous infusion and intermittent bolus administration of 0.1% ropivacaine with 0.0002% fentanyl for epidural labor analgesia
por: Patkar, Chinmayi Surendra, et al.
Publicado: (2015)

Cystoid macular edema associated with omidenepag isopropyl in a phakic eye with an implantable collamer lens: a case report
por: Bae, Byung-Jin, et al.
Publicado: (2023)

Effect of Current Density on the Corrosion Resistance and Photocatalytic Properties of Cu-Ni-Zn(0.96)Ni(0.02)Cu(0.02)O Nanocomposite Coatings
por: Tan, Haifeng, et al.
Publicado: (2023)

Iris Morphological Features in Patients with 360° Angle-Closure Neovascular Glaucoma: An Anterior Segment Optical Coherence Tomography Study
por: Kobayashi, Yui, et al.
Publicado: (2018)

Severity Classification of Conjunctival Hyperaemia by Deep Neural Network Ensembles
por: Masumoto, Hiroki, et al.
Publicado: (2019)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Nakakura, Shunsuke, et al.
Publicado: (2012)

Comptia Cloud+ study guide exam CV0-002
por: Montgomery, Todd, et al.
Publicado: (2018)

Study on the growth of Al-doped ZnO thin films with (112̄0) and (0002) preferential orientations and their thermoelectric characteristics
por: Luo, Jing-Ting, et al.
Publicado: (2018)

Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2022)

Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial
por: Wang, Ming, et al.
Publicado: (2023)

A randomized, controlled comparison of macroscopic conjunctival hyperemia in patients treated with bimatoprost 0.01% or vehicle who were previously controlled on latanoprost
por: Craven, E Randy, et al.
Publicado: (2010)

Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine
por: Tanihara, Hidenobu, et al.
Publicado: (2023)

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
por: Panarelli, Joseph F., et al.
Publicado: (2023)

Effect of ripasudil on diabetic macular edema
por: Minami, Yoshiro, et al.
Publicado: (2019)

Ripasudil in a Model of Pigmentary Glaucoma
por: Wang, Chao, et al.
Publicado: (2020)

In vitro comparison of apical leakage in root canals obturated with 0.04 and 0.02 tapered gutta-percha
por: Bidar, Maryam, et al.
Publicado: (2010)

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
por: Shimizu, Yoshie, et al.
Publicado: (2015)

Thermoelectric Properties of Ca(1−x)Gd(x)MnO(3−δ) (0.00, 0.02, and 0.05) Systems
por: Bhaskar, Ankam, et al.
Publicado: (2012)

The Whole Macular Choroidal Thickness in Subjects with Primary Open Angle Glaucoma
por: Nakakura, Shunsuke, et al.
Publicado: (2014)

Giant Negative Electrocaloric Effect in Anti-Ferroelectric (Pb(0.97)La(0.02))(Zr(0.95)Ti(0.05))O(3) Ceramics
por: Zhao, Ying-Cheng, et al.
Publicado: (2019)

CompTIA cloud+: certification study guide (exam CV0-002)
por: Wilson, Scott, et al.
Publicado: (2018)

CompTIA cloud+ certification practice exams (Exam CV0-002)
por: Lachance, Daniel
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1u97d4na18nbkik71beh1colsh